US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist

4.160
-0.050-1.19%

Close May 3 16:00 ET

4.090
-0.070-1.68%

Post 19:32 ET

247.16MMarket Cap-8156P/E (TTM)

Aldeyra Therapeutics Stock Forum

Trytosaveabit

Apr 25 19:28

Update

$Aldeyra Therapeutics(ALDX.US)$ Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day

Joshua Grabar

Apr 12 00:20

ATTENTION LONG-TERM ALDEYRA THERAPEUTICS, INC. (NASDAQ: ALDX) INVESTORS

$Aldeyra Therapeutics(ALDX.US)$ATTENTION LONG-TERM ALDEYRA THERAPEUTICS, INC. (NASDAQ: ALDX) INVESTORS
Grabar Law Office is investigating claims on behalf of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) shareholders. The investigation concerns whether certain officers of Aldeyra have breached their fiduciary duties owed to the company.
Current Aldeyra shareholders who have continuously held Aldeyra shares since prior to Januar...

Trytosaveabit

Apr 4 18:31

Insider buy! Almost 2M

$Aldeyra Therapeutics(ALDX.US)$ 10% Shareholder PERCEPTIVE ADVISORS LLC purchased 504.27K shares of Common Stock on Apr 1, 2, 3, 2024 at an average price of $3.84 for a total value of $1.93 million.

Moomoo AI

Mar 15 18:28

CEO's recent share sale is viewed negatively, with no insider purchases recorded last year. Low insider ownership raises concerns about alignment with company's long-term growth. Lack of insider buying and recent selling activity make the stock less attractive.

Have Insiders Sold Aldeyra Therapeutics Shares Recently?

Trytosaveabit

Dec 22, 2023 06:15

Update

$Aldeyra Therapeutics(ALDX.US)$ • AbbVie (NYSE:ABBV) has extended the period during which it can exercise an option for a co-development, co-commercialization and license agreement with Aldeyra Therapeutics (NASDAQ:ALDX) for dry eye candidate reproxalap.
• As a result, AbbVie (ABBV) is paying a non-refundable $5M option extension fee.
• The original option agreement was signed in late October.
• AbbVie (ABBV) now can exercise its option by the earlier of (a) the 10th business day after ...

Trytosaveabit

Dec 20, 2023 05:04

Ahh!

$Aldeyra Therapeutics(ALDX.US)$ The daily finished with a big ole hammer! So lets see if it gets a nice PI tomorrow? Hell why not get a head start in AH? hehehe

Moo Top

Dec 19, 2023 20:41

Like how it was shorted... going for the pull back...

$Aldeyra Therapeutics(ALDX.US)$

Trytosaveabit

Dec 19, 2023 20:09

News

$Aldeyra Therapeutics(ALDX.US)$Moomoo 24/7· 2 mins ago
Aldeyra Therapeutics' Phase 2 Trial Of ADX-629 For Atopic Dermatitis Shows Statistically Significant And Clinically Relevant Improvement In Investigator-assessed And Patient-reported Outcomes Across Different Physiological And Psychosocial Assessments